Craig Gilgallon
Fundador en Cingulate Works, Inc. .
Fortuna: 8 183 $ al 30/04/2024
Perfil
Craig Steven Gilgallon is the founder of Cingulate Works, Inc. (founded in 2013) and Cingulate, Inc. (founded in 2013).
He held the titles of Secretary, Executive VP & General Counsel at both companies.
Mr. Gilgallon is also the founder of Cingulate Therapeutics LLC.
Mr. Gilgallon's current job is as a Partner at Pawar Gilgallon & Rudy LLC (since 2012).
Mr. Gilgallon's education history includes an undergraduate degree from Ithaca College and a graduate degree from Thomas Jefferson School of Law.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CINGULATE, INC.
0.24% | 15/04/2024 | 9 742 ( 0.24% ) | 8 183 $ | 30/04/2024 |
Cargos activos de Craig Gilgallon
| Empresas | Cargo | Inicio |
|---|---|---|
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Fundador | 01/01/2013 |
| Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 01/01/2012 |
Antiguos cargos conocidos de Craig Gilgallon.
| Empresas | Cargo | Fin |
|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Fundador | 15/12/2023 |
| CINGULATE INC. | Fundador | 15/12/2023 |
Formación de Craig Gilgallon.
| Thomas Jefferson School of Law | Graduate Degree |
| Ithaca College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Pawar Gilgallon & Rudy LLC |
- Bolsa de valores
- Insiders
- Craig Gilgallon